Methods for rapidly transforming monocots

ABSTRACT

The present invention provides methods for transforming monocot plants via a simple and rapid protocol, to obtain regenerated plants capable of being planted to soil in as little as 4-8 weeks. Associated cell culture media and growth conditions are also provided, as well as plants and plant parts obtained by the method. Further, a method for screening recalcitrant plant genotypes for transformability by the methods of the present invention is also provided. Further, a system for expanding priority development window for producing transgenic plants by the methods of the present invention is also provided.

This application is a continuation of U.S. application Ser. No.13/791,186, filed Mar. 8, 2013, which application is a divisional ofU.S. application Ser. No. 11/848,648, filed Aug. 31, 2007 (issued asU.S. Pat. No. 8,395,020), which application claims the priority of U.S.provisional application Ser. No. 60/841,519, filed Aug. 31, 2006, theentire disclosures of all of which are incorporated herein by reference.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention generally relates to plant biotechnology. Morespecifically, it relates to improved methods for transformation ofmonocots with a gene of interest.

2. Description of the Related Art

Genomics-based approaches in plant biotechnology have enabledidentification and isolation of a large number of genes and havenecessitated the need for reliable and efficient high-throughputtransformation production systems for testing the utility of these genesby transforming them into economically important monocots such as corn.Agrobacterium-mediated transformation of monocots such as corn, rice,and wheat is a widely used experimental approach, often with the use ofmeristematic tissue such as immature embryos as the explants of choice(e.g. Ishida et al., 1996; Zhao et al., 2001; Frame et al., 2002). Forrice, transformation of imbibed seeds has also been reported (Toki etal., 2006). To date, the most common methods following the contacting ofcells with Agrobacterium include: culturing explant tissue such asimmature embryos (“co-culture”), possibly including a “delay” or“resting” (non-selective) step, and followed by culture on selectionmedium containing auxin(s) allowing de-differentiation of cells to formcallus. During this callusing phase, transformed resistant callus tissueis selected in the presence of an appropriate selection agent on aselection medium. This is followed by growth of cells under conditionsthat promote differentiation of the callus and regeneration of thecallus into plants on regeneration and rooting media. This process hastypically required at least 10-12 weeks to produce plants that can betransferred to soil for further growth. The process also requiresseveral manual transfers of tissue throughout the transformation processand uses several different types of media.

Thus use of standard transformation and regeneration protocols is timeconsuming and inefficient, and negatively impacts the transgenic productdevelopment timeline, given that there is usually a seasonally limited“priority development window” for making decisions regarding whichgenetic constructs to prioritize for use in larger scale transformationwork based on results obtained during initial research. There istherefore a need in the art of monocot transformation to producetransgenic plants quickly to provide more time and flexibility formaking research and product development decisions during a prioritydevelopment window. Such a high throughput system for corntransformation could produce a large number of transgenic plants fortesting genes and creating useful plants while lowering material andlabor costs.

Further, embryogenic culture responses of different breeding linesdiffer greatly, limiting the genotypes of crops such as corn that can betransformed. Accordingly, some lines can form embryogenic callusreadily, although many, in general, fail to form any embryogenic callus.Such lines are often considered “recalcitrant” lines. This can requireuse of non-elite lines for transformation, which can require manygenerations of breeding to produce agronomically-elite transgenicvarieties. Thus there is further a need for transformation methods thatallow transformation of hitherto “recalcitrant” corn genotypes to allowa wider choice of transformable lines for product development, as wellas for screening such genotypes for their potential transformability.

SUMMARY OF THE INVENTION

In one aspect, the invention provides a method for producing atransgenic monocot plant comprising: a) transforming an explant with atleast a first selected DNA; b) culturing the explant in a first culturemedium comprising an effective ratio of cytokinin and auxin in order topromote development of regenerable structures capable of root and/orshoot formation; and c) culturing the explant in at least a secondand/or third culture medium that supports the simultaneous growth ofroot and shoot tissues, to produce a regenerated transgenic monocotplant; wherein the regenerated transformed monocot plant is producedwithin about 4-8 weeks of transforming the explant. The method mayfurther comprise, in one embodiment, transferring the regeneratedtransgenic monocot plant to a plant growth medium. In particularembodiments, the growth medium is a non-sterile matrix, including anon-sterile matrix comprised in a plug.

In certain embodiments, the regenerable structures are formed withinabout 6-14 days of transforming the explant. In other embodiments, step(b) is completed within about 6-14 days of transforming the explant. Inanother embodiment, step (b) is carried out for a length of from about 6to about 12 days. In yet other embodiments, steps (a) and (b) arecarried out without proliferating a callus for more than about 10 daysto about two weeks following transforming of the explant. In certainembodiments, the first culture medium comprises a bactericidal compound,such as carbenicillin or other compound that inhibits growth of theRhizobia, including Agrobacterium, used for transforming the explant. Inother embodiments, the second and/or third culture medium comprisessucrose, at a concentration higher than is found in the first culturemedium. In particular embodiments, the first culture medium comprisesLynx 1947.

In other embodiments, step (c) comprises culturing the explant in anadded plant growth regulator-free liquid culture medium that supportsthe simultaneous growth of root and shoot tissues, to produce aregenerated transgenic monocot plant. In particular embodiments, theculture medium that supports the simultaneous growth of root and shoottissues comprises Lynx 2067. In further embodiments, step (c) is begunwithin about 4-8 weeks of transforming the explant.

In certain embodiments, the ratio of cytokinin to auxin in the firstculture medium is from about 0.005 to about 0.03 (w/w). In otherembodiments the ratio of cytokinin to auxin in the first culture mediumis from about 0.005 to about 0.03 on a molar basis. In particularembodiments the cytokinin may be selected from the group consisting ofBAP, zeatin, kinetin, and TDZ; and the auxin may be selected from thegroup consisting of IAA, 2,4-D, NAA, IBA, and dicamba. In otherembodiments, the cytokinin and/or auxin in the first culture medium maycomprise a plant growth-regulatory effect equivalent to these amountsand ratios of the above listed cytokinins or auxins.

In yet other embodiments, step (c) further comprises culturing theexplant in a second culture medium comprising an increased ratio of ashoot forming growth regulator to auxin relative to the first medium topromote development of root(s) and shoot(s) simultaneously. Inparticular embodiments the medium of step (c) is Lynx 2068 and/or Lynx2202.

Certain embodiments of the methods of the present invention may furthercomprise culturing the explant in a second and/or third culture mediumlacking added plant growth regulators. In some embodiments the ratio ofshoot forming growth regulator to auxin in the second medium is fromabout 0.02 to about 0.06 (w/w). In particular embodiments, the secondmedium is Lynx 2202 or Lynx 2068. In certain embodiments, fresh growthmedium is not added subsequent to the start of step (c).

In yet other embodiments, the first culture medium comprises about 0.001mg/L to about 10 mg/L of cytokinin and about 0.1 mg to about 15 mg/Lauxin, for instance about 0.005 mg/L cytokinin to about 0.05 mg/Lcytokinin, and about 0.1 mg/L auxin or 0.2 mg/L auxin to about 0.5 mg/Lauxin. In still further embodiments, the explant is further cultured ona fourth medium between culturing on the first and the second medium,wherein the fourth medium comprises an effective amount of auxin andcytokinin to promote callus proliferation. In particular embodiments,the fourth medium is Lynx 2063.

In other embodiments, the explant is further cultured on a fifth mediumbetween culturing on the second and the third medium, wherein the fifthmedium comprises an amount of cytokinin effective to promote shootgrowth. In particular embodiments, the fifth medium is Lynx 2066.

In certain embodiments, transforming the explant comprisesbacterially-mediated transformation. In particular embodiments,bacterially mediated transformation is carried out using a bacteriumselected from the group consisting of Agrobacterium sp., Rhizobium sp.,Sinorhizobium sp., Mesorhizobium sp., and Bradyrhizobium sp.

In other embodiments, the second and/or third culture medium comprisesan amount of auxin that is reduced relative to the amount in the firstmedium, cytokinin, abscisic acid, or a combination. In a particularembodiment, the second and/or third culture medium comprises less thanhalf as much auxin or auxin-like plant growth regulator activity as thefirst medium.

In certain embodiments, the first culture medium and culture medium thatsupports the simultaneous growth of root and shoot tissues are liquidmedia. In other embodiments, the first culture medium is a semi-solidmedium. In particular embodiments, each medium used subsequent to thefirst culture medium is a liquid medium. In certain embodiments, steps(b) and (c) are carried out in a single container.

In certain embodiments, the monocot plant is a corn, rice, sorghum,wheat, rye, millet, sugarcane, oat, triticale, switchgrass, or turfgrassplant. In a particular embodiment, the monocot is a corn plant.

In another aspect, the invention provides a system for expanding apriority development window for producing transgenic plants, comprising:(a) selecting a candidate DNA segment of interest for producing atransgenic plant based at least in part on data collected in a firstfield test; (b) preparing a transgenic monocot plant comprising thecandidate DNA segment by the method of claim 1; and (c) assaying thetransgenic plant for a desired phenotype and/or genotype in at least asecond field test conducted in a growing season subsequent to that inwhich the first field test is conducted. In particular embodiments, oneor both of the first field test or second field test are conducted inthe mid-west United States. In certain embodiments, assaying thetransgenic plant comprises measuring agronomic performance. Inparticular embodiments, the second field test is a hybrid yield test. Inyet other embodiments, the second field test is performed two growingseasons after the first field test.

A further aspect of the present invention provides a method forscreening cells of a crop plant line for transformability, comprising(a) culturing crop plant explants on a growth medium that supportsproduction of shoot primordia within about 1-2 weeks; (b) culturing theshoot primordia under conditions that support shoot elongation for atleast about a further week in the dark to obtain growing shoot tissueand/or plantlets; and (c) culturing the tissue or plantlets of step (b)on a plant growth medium for at least about a further week to obtainshoot buds and/or plants; wherein the transformability of the cells ismeasured by the ability of shoot primordia to produce shoot buds and/orplants following step (c).

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1. Line diagram of the control (“BPD”) transformation method andtwo illustrative embodiments of the present invention showing number ofculture steps and tissue transfer and media transfer/change steps. Onesmall block represent about one week duration. Dark arrows representphysical transfer of explants to a new container. Arrows with patternrepresent aspiration and media change. Arrows with stripes representaddition of media without aspiration.

FIG. 2. The presence of cytokinin during the first medium enablesefficient and rapid transformation by facilitating production of shootprimordia. Explants were histochemically assayed for gus expression 10days post transformation and showed large transgenic sectors (TS) andshoot primordium (SP).

FIG. 3. Four (A), six (B), and seven (C) weeks old transgenic cornplants produced by the method of the present invention.

FIG. 4. Line diagram showing further reduction in number of culturesteps, tissue transfer steps, and media transfer/change steps. One smallblock represent about one week duration. Dark arrows represent physicaltransfer of explants to a new container. Arrows with pattern representaspiration and media change. Arrows with stripes represent addition ofmedia without aspiration.

FIG. 5. Impact of Rapid Liquid Culture (RLC) protocol on transformationinitiation during the “priority development window”.

DETAILED DESCRIPTION OF THE INVENTION

The invention provides improved transformation methods thatsubstantially reduce the time required for production of transgenicplants and expands the range of genotypes that can be transformed. Inone embodiment, use of liquid media combined with efficientplant-handling procedures and simplified media and culture steps offersadvantages such as shorter production time, higher through-put, lowermaterial and labor costs, and ergonomic safety benefits, whilemaintaining transformation frequency (TF) at a useful level, or evenimproving TF.

Further, by allowing production of transformed corn plants via suchrapid methods, it is now possible to more efficiently use aseasonally-affected priority development window, i.e. for makingdecisions regarding transformation constructs and events in view ofplanting seasons at various locations, as well as based on the resultsof field tests conducted within those locations. These locationsinclude, for instance, the United States Corn Belt, including all ormost of Iowa, Indiana, Illinois, and Ohio, and parts of South Dakota,Nebraska, Kansas, Minnesota, Wisconsin, Michigan, Missouri, andKentucky. This reduces barriers for planning and prioritizinggene-construct and plant transformation-event studies. Thus, shorteninga corn transformation protocol from 10-12 weeks to 6-7 weeks or lesseffectively expands the product development window by 5-6 weeks,allowing for up to twice the transformation capacity in a timeframe suchthat yield testing of additional transformants initiated during thepriority development window is possible in the second growing seasonsubsequent to the occurrence of the transformation event.

In certain aspects, the inventors found that the use of liquid mediawith a matrix at various steps instead of the commonly used semi-solidmedia may result in lower TF. However, use of liquid selection andregeneration media with a delay medium containing cytokinin resulted insimilar TF as with semi-solid selection and regeneration medium.Therefore, a faster method has been developed by combining previouslyseparate delay and co-culture steps by use of one medium whilemaintaining/improving the TF. The presence of cytokinin in co-cultureand delay medium (the first medium) triggers an early regenerationresponse while reducing callusing or simultaneous callusing and plantregeneration, thus leading to faster regeneration. The presence ofcarbenicillin, a bactericidal compound in co-culture medium allowsexplants to be cultured on the same medium for an extended period i.e.7-14 days after DNA delivery by Agrobacterium-mediated transformation.Further, the traditional separate callus proliferation and selectionstep(s) can be eliminated, while still achieving an acceptable TF, asexplants may be directly transferred to a second and/or third mediumthat promotes shoot bud primordia growth and development. Thus,importantly, previously “recalcitrant” genotypes that have shown limitedembryogenic response and transformability via a callus-based approachmay now be directly used as transformation targets, and without furtherphysical manipulation of explant material i.e. sub-culturing with manualtransfer to different media, by use of culture regimes as describedherein.

The transformation methods described herein provide a significantimprovement over the current transformation method known in the art. Byusing such methods, it was surprisingly found that a transformed plantcan be produced within 4-6 weeks after contacting of cells with atransforming agent that is ready for transplanting into a growth matrixsuch as plug and/or soil and is produced by more efficient proceduresand with a broader range of genotypes. In some aspects, the methods alsoemploy liquid medium with a suitable support matrix. Use of the liquidculture reduces the number of transfer steps from six to as few as twoor three. Still further, the step of selecting a transformed cell andregeneration can be achieved in a single container until plants aretransferred to soil. The methods are thus suitable for a high-throughputautomated production system.

Certain monocot genotypes respond poorly to embryogenic cultureconditions. That is, embryos, or embryogenic callus leading to efficientregeneration, are not produced under these conditions. Such“recalcitrant” genotypes have transformation frequencies at or near zerowhen previously described methods are attempted. Thus, the currentmethods that can be used to transform a wide variety of genotypes,especially recalcitrant lines, provide a wider choice of transformablelines and represent a significant advance in the art.

Further, methods for assessing the transformability of cells of amonocot crop plant line have typically focused on measuring the abilityof a given line to produce embryogenic callus under the rightconditions. These conventional approaches for screening for embryogeniccallus formation utilize immature embryos that are isolated and grown ontissue culture media capable of supporting embryogenic callus formation.Just as important for transformability is the ability of a cell line tosustain such embryogenic callus growth over time, since some cell linesdisplay a brief burst of callus formation, but do not subsequentlymaintain their embryogenic potential.

Thus, one embodiment of the present invention comprises a novel methodto screen crop plant cells for transformability. This method, in oneaspect, comprises culturing explants (e.g. maize immature embryos) on amedium capable of producing shoot primordia in a short time (e.g. within1-2 weeks, for instance within 1 week). The tissues are then transferredto a regeneration/elongation medium for about 2-3 weeks under darkconditions, before being placed on a growth medium for about 2-3additional weeks. The ability of lines to regenerate shoot buds and/orplants under these conditions indicates their transformation competenceby the methods of the present invention, including those in which nocallus growth phase is provided, or in which a period of callus growthis substantially reduced from previous cell culture regenerationmethods.

A method of the invention in one embodiment also includes exposing atransformable explant to a transforming agent. Suitable explants includetransformable plant parts such as callus, cells and embryos. In specificembodiments the explant may be an immature embryo of about 1.0-3.0 mm inlength, for instance the embryo size may be between about 1.6-2.6 mm inlength, about 8-14 days post pollination (DAP), including an embryo sizeof about 2.0 mm at about 10-12 days post pollination. The stages of cornembryo development and morphology have been described (e.g.Matthys-Rochon et al., 1998, and references therein). Suitabletransforming agents include plant transforming bacteria carrying a DNAconstruct to be transferred. Examples of such bacteria includeAgrobacterium sp., Rhizobium sp., Sinorhizobium sp., Mesorhizobium sp.,and Bradyrhizobium sp. (e.g. Broothaerts et al., 2005; U.S. patentapplication Ser. No. 11/749,583). The explant can also be exposed to theDNA construct via direct uptake, microinjection, electroporation, andmicro-projectile bombardment, or by any other method known to thoseskilled in the art.

Typically, a DNA construct includes one or more expression units. Theseexpression units generally comprise in 5′ to 3′ direction: a promoter,nucleic acid encoding for a useful trait or for gene suppression, a 3′untranslated region. Several other expression elements such as 5′ UTRs,organellar transit peptide sequences, and introns (especially formonocots) are usually added to facilitate expression of the trait. Othergenetic components that serve to enhance expression or affect thetranscription or translation of a gene in a plant are also envisionedfor use.

Numerous plant promoters are known to those of skill in the art. Suchpromoters include but are not limited to the nopaline synthase (NOS)promoter, cauliflower mosaic virus (CaMV) 19S and 35S promoters (e.g.see U.S. Pat. No. 5,352,605), the enhanced CaMV 35S promoter (e35S), assRUBISCO promoter, and an actin promoter (e.g. rice actin promoter; seeU.S. Pat. No. 5,641,876), among others. The DNA construct may include asecond expression unit wherein the nucleic acid encodes a maker proteinfor selecting, screening, or scoring a transformed cell.

For the practice of the present invention, compositions and methods forpreparing and using constructs and host cells are well known to oneskilled in the art, see for example, Sambrook, et al. (2000). Methodsfor making transformation constructs particularly suited to planttransformation include, without limitation, those described in U.S. Pat.Nos. 4,971,908, 4,940,835, 4,769,061 and 4,757,011, all of which areherein incorporated by reference in their entirety.

Normally, the expression units are provided between one or more T-DNAborders on a transformation construct. The transformation constructspermit the integration of the expression unit between the T-DNA bordersinto the genome of a plant cell. The constructs may also contain theplasmid backbone DNA segments that provide replication function andantibiotic selection in bacterial cells, for example, an Escherichiacoli origin of replication such as ori322, a broad host range origin ofreplication such as oriV or oriRi, and a coding region for a selectablemarker such as Spec/Strp that encodes for Tn7 aminoglycosideadenyltransferase (aadA) conferring resistance to spectinomycin orstreptomycin, or a gentamicin (Gm, Gent) selectable marker gene. Forplant transformation, the host bacterial strain is often Agrobacteriumtumefaciens ABI, C58, LBA4404, EHA101, or EHA105 carrying a plasmidhaving a transfer function for the expression unit. Other strains knownto those skilled in the art of plant transformation can function in thepresent invention.

After contacting an explant with a transforming agent, the explant maybe cultured on a first medium (e.g. Lynx #1947) that combines theattributes of a co-culture and a delay medium due to the presence of abactericidal compound such as Carbenicillin. Such a medium comprises acytokinin and an auxin. By providing an effective amount of plant growthregulators and appropriate ratio of cytokinin to auxin or any othergrowth regulators that are known to affect callusing and/or shoot budformation, such a medium allows subsequent regeneration of tissues,including transformed tissues, to begin without requiring a separatecallus proliferation phase or a sustained embryogenic response. Theeffective growth regulator(s) concentrations and/or ratio of cytokininto auxin could vary from genotype to genotype and the type of plantspecies used. Subsequent to the first medium, in certain embodiments theexplant may be cultured on a growth regulator free medium to promoteplant regeneration. In certain embodiments this medium is a liquidmedium.

The methods provided by the invention may be carried out using genotypesthat are capable of producing a classical embryogenic callus response,as well as for recalcitrant genotypes that fail to show appreciableamount of embryogenic culture response, or sustained culture response,with other previously known culture methods. The culture period on thefirst medium may be varied depending upon the need for a particular TF.In one embodiment, the culture period on the first medium is from about6 or 7 to about 10-14 days. Earlier regeneration also reduces the numberof clonal (i.e. sister) plants, including non-transformed plants, thattend to arise following callusing and that may make downstream screeningless efficient. The cytokinin may be added to the inoculation orco-culture medium. Alternatively, the cytokinin may be produced by acytokinin synthesis gene such as a gene for isopentenyl transferase(e.g. U.S. Pat. No. 6,294,714) within the explant of a transformed line.

Examples of various cytokinins that are suitable for use either alone orin combination with the present method include 6-Benzyl aminopurine(BAP), kinetin, zeatin, adenosine phosphate, thidiazuron (TDZ) and othercytokinin like compounds. Examples of various auxins that are suitablefor use either alone or in combination with the present method includeIAA, 2,4-D, NAA, IBA, dicamba, and other auxin like compounds. One ofskill in the art of plant cell culture and transformation would be ableto determine appropriate levels of shoot forming plant growth regulatorsand auxins, and appropriate ratios of the two, that are suitable for usewith the present invention. For instance, levels of these or other plantgrowth regulators with a functionally equivalent level of activity as,for instance, BAP and/or 2,4 D in corn or in another crop plant, may bedetermined by varying the levels of such growth regulators present ingrowth media while explants are grown in the media, and following thegrowth of the explants and tissues derived therefrom. Thus, if otherplant growth regulators are used, they would nevertheless comprise aplant growth-regulatory effect equivalent to these contemplated amountsand ratios of the above listed cytokinins or auxins.

A dedifferentiated explant comprising at least one shoot primordium canbe produced after co-culture/delay on the first medium and may becultured on a second medium including an increased ratio of a shootforming growth regulator, such as a cytokinin or ABA, to auxin than thefirst medium. Alternatively, the second and/or third medium may comprisea reduced amount of auxin than the first medium, and may furthercomprise an effective amount of sucrose higher than the first medium forreducing proliferation of callus and faster regeneration. For instance,50 g/L sucrose in the second medium and 60 g/L in the third medium maybe utilized. In another alternative, the second medium and/or thirdmedium may comprise an effective amount of a shoot forming growthregulator such as a cytokinin and/or ABA only, with no added auxin orauxin-like activity. Subsequently, the explant may be cultured on athird culture medium comprising little or no plant growth regulators forshoot elongation and root production.

In one embodiment, the method combines the traditional co-culture anddelay medium into a first medium thereby reducing the number of mediarequired for transformation and subsequent culture from five to four. Inanother embodiment, the method eliminates the callusproliferation/selection medium, two regeneration medium, one rootingmedium and provides modified regeneration/elongation media that may lackappreciable amounts of added plant growth regulator, thereby reducingthe number of media required for transformation from six to three. Inyet another embodiment, the method uses only the first medium and thethird medium thereby reducing the number of media required fortransformation from six to two.

In other embodiments, the first medium is a semi-solid medium and theother media are liquid media. In yet another embodiment, all media usedare liquid media. However, it will be apparent to those skilled in theart to use a combination of semi-solid or liquid media and to use onlyone or more of the modifications provided herein, depending upon theirneed.

In a specific embodiment, the explant is cultured on the first culturemedium, such as Lynx #1947, for about 7-14 days, on the second culturemedium, such as Lynx #2202, for about 7 days, and on the third culturemedium, such as Lynx #2067, for about 14-28 days. However, the number ofdays on one or more media can be increased or decreased by visualinspection of the growth of the transgenic plant by those skilled in theart. In another embodiment, the explant is additionally cultured on afourth medium between the first and the medium for about 14 days and ona fifth culture medium for about 7 days between the and the thirdculture medium. The fourth medium, such as Lynx #2063, can contain plantgrowth regulators including auxin, cytokinin, and AgNO₃, and isformulated to support callus proliferation. The fifth medium, such asLynx #2066, can contain cytokinin but generally no auxin, and isformulated to support shoot growth and elongation. In certainembodiments, the added second, third, fourth, and/or fifth media maycomprise no effective amount of a plant growth regulator, whilepromoting the development of regenerated plants. The second or othersubsequent media may be liquid, semi-solid, or solid media. Inparticular embodiments, only two media may be employed, i.e. aco-culture/delay medium such as, for instance, Lynx 1947, and asubsequent medium, for instance derivatives of Lynx 2067 and Lynx 2066(also described as “third” and “fifth medium” respectively), lackingappreciable amounts of an auxin, in a method to obtain transformedregenerated plants within 4-8 weeks of transformation (For mediacompositions see e.g. Tables 2, 3).

The number of days on one or more media can be increased or decreased byvisual inspection of the explants by those skilled in the art. Theinvention thus provides a regenerated plant, and parts thereof, that iscapable of growth in a soil-based medium or any other non-sterile matrixwithin 4-6 weeks after the explant from which it is derived wascontacted by a transforming agent, such as by transforming an explantwith a selected DNA. In a particular embodiment, 4-8 weeks oldregenerated plants are transplanted into plugs (Q Plugs by InternationalHorticultural Technologies, Hollister, Calif.) for further growth anddevelopment and initial screening, for instance to determine theirgenotype and/or phenotype with respect to a transgene of interest.

In other embodiments, the second, third, fourth, and/or fifth media alsoinclude a selection agent such as the herbicide glyphosate forterminating or at least retarding growth of most of the cells, tissue,or organ into which the DNA construct has not been delivered. Othersuitable selection agents that may be used alone or in combination,include, but are not limited to auxin-like herbicides such as dicamba or2,4-D, MCPA, 2,4-DB, glufosinate, acetolactate synthase inhibitors,protoporphyrinogen oxidase inhibitors, andhydroxyphenyl-pyruvate-dioxygenase inhibitors, neomycin, kanamycin,paramomycin, G418, aminoglycosides, spectinomycin, streptomycin,hygromycin B, bleomycin, phleomycin, sulfonamides, streptothricin,chloramphenicol, methotrexate, 2-deoxyglucose, betaine aldehyde,S-aminoethyl L-cysteine, 4-methyltryptophan, D-xylose, D-mannose,benzyladenine-N-3-glucuronidase. Examples of genes providing toleranceto such selection agents are disclosed in Miki and McHugh, (2004).

A variety of plant tissue culture media are known that, whensupplemented appropriately, support plant tissue growth and development.These tissue culture media can either be purchased as a commercialpreparation or custom prepared and modified by those of skill in theart. Reagents are commercially available and can be purchased from anumber of suppliers (see, for example, Sigma Chemical Co., St. Louis,Mo.; and PhytoTechnology Laboratories, Shawnee Mission, Kans.). Examplesof such media include, but are not limited to, those described byMurashige and Skoog (1962); Chu et al. (1975); Linsmaier and Skoog(1965); Uchimiya and Murashige (1962); Gamborg et al. (1968); Duncan etal. (1985); McCown and Lloyd (1981); Nitsch and Nitsch (1969); andSchenk and Hildebrandt (1972), or derivations of these mediasupplemented accordingly. Those of skill in the art are aware that mediaand media supplements such as nutrients and growth regulators for use intransformation and regeneration are usually optimized for the particulartarget crop or variety of interest. One may also select variouscomponents such as basal salts, vitamins, carbon source from one or theother medium to obtain desired growth and development. Plant growthmedia used in a prior method (e.g. Cai et al.; U.S. Patent ApplicationPublication 20040244075, and incorporated herein by reference) are shownin Table 1. Preferred media compositions used in the present methods arelisted in Tables 2 and 3. Differences between the recipes used in thepresent invention and the standard recipes used in the conventionalmethods of monocot transformation are, for instance, that conventionalmethods use medium that allows callus proliferation and selection,followed by regeneration and growth of the transgenic event. Incontrast, the media of the present invention allow just enough callusformation for formation of shoot primordia thereby avoiding chimericplant formation and allowing efficient selection through simultaneouscallus formation and plant regeneration, in a manner to allowhigh-frequency transformation.

In general, a 1^(st) medium may function as a co-culture and delaymedium, and comprises plant growth regulators such as an auxin (e.g.2,4-D), a cytokinin (e.g. BAP), and silver nitrate, as well asacetosyringone to facilitate Agrobacterium-mediated transformation. The1^(st) medium may also contain a bactericidal compound such ascarbenicillin which allows explants to be cultured on the same mediumfor an extended period i.e., 7-14 days after contacting the explant witha transforming agent. A 2^(nd) medium (e.g. 2202) may also comprise suchplant growth regulators, but auxin is reduced. Importantly, this 2^(nd)medium may function as a regeneration medium. A 3^(rd) medium (e.g.2067) lacks growth regulators, and functions as a regeneration or shootelongation medium. A 4^(th) medium (e.g. 2063) comprises a similaramount of growth regulators as the 1^(st) medium, and may function tosupport callus proliferation. A low level of a selective agent may alsobe present, to favor growth of transformed tissue. A 5^(th) medium (e.g.2066) lacks auxin and silver nitrate, and has a low level of cytokinin,and supports regeneration. Alternatively, media added subsequently tothe 1^(st) medium may comprise no effective amount of a plant growthregulator, while supporting development and growth of a regeneratedplant. In a particular embodiment, a different 2^(nd) medium with noauxin but some cytokinin (e.g. 2347, 2348, 2415, 2414; see Table 3) mayalso be employed as the regeneration medium which can supportregeneration and elongation in place of the initially described 2^(nd)medium (i.e. 2202). Media 2348, 2415, 2414 are essentially the same as2066 but with silver nitrate, and contain differing amounts ofglyphosate. Medium 2347 is essentially the same as 2067, but with silvernitrate and a cytokinin. Modifications of such media may be made by oneof skill in the art of plant cell transformation and tissue culture,depending on the species and genotype of the subject explant tissue,while maintaining the described cell culture attributes.

TABLE 1 Media compositions used in a previous method (Cai et al.; U.S.Patent Applic. Publn. 2004/00244075). 1278 1073 1071 (MSW (MS/6BA)(MSOD) Media Components/L 1233 50 + BAP), (1^(st) (2^(nd) 1084(Suppliers) (co-culture) (selection) regeneration) regeneration)(rooting) MS Basal Salts 2.165 g 4.33 g 4.33 g 4.33 g 2.165 g(Phytotech) MS Vitamins (100X) 10 mL 10 mL 0 0 0 (Phytotech) MS FrommVitamins 0 0 1 mL 1 mL 0 (1000X)* BAP (Sigma) 0 0.01 mg 3.5 mg 0 0Thiamine HCL (Sigma) 0.5 mg 0.5 mg 0 0 0 2,4-D (Phytotech) 3 mg 0.5 mg 00 0 NAA (Sigma) 0 0 0 0 0.5 mg IBA (Sigma) 0 0 0 0 0.75 mg Sucrose(Phytotech) 20 g 30 g 30 g 0 20 g Glucose (Phytotech) 10 g 0 0 10 g 0Maltose (Phytotech) 0 0 0 20 g 0 Proline (Sigma) 115 mg 1.38 g 1.38 g 00 Casamino Acids 0 0.5 g 0.05 g 0.5 0 (Difco) Asparagine 0 0 0 0.15 0monohydrate (Sigma) Myo-inositol (Sigma) 0 0 0 0.1 g 0 Low EEO Agarose5.5 g 0 0 0 0 (Sigma) Phytagel (Sigma) 0 3 g 3 g 3 g 3 g Acetosyringone200 uM 0 0 0 0 (Aldrich) Carbenicillin 500 mg 500 mg 250 mg 250 mg 0(Phytotech) Glyphosate (Gateway 0 0.1 mM 0.1 mM 0.1 mM 0.1 mM Chemical)Silver Nitrate (Sigma) 3.4 mg 3.4 mg 0 0 0 pH 5.2 5.8 5.8 5.8 5.8*Comprising 1250 mg/L nicotinic acid (Sigma), 250 mg/L pyridoxine HCl(Sigma), 250 mg/L thiamine HCl (Sigma), and 250 mg/L calciumpantothenate (Sigma).

TABLE 2 Media compositions used in various aspects of the presentinvention. Media Components/L 1947 2063 2202 2066 2067 (Suppliers) 18982232 2233 (1^(st)) (4^(th)) (2^(nd)) (5^(th)) (3^(rd)) 2068 MS BasalSalts 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g(Phytotech) MS Vitamins 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL10 mL (100X) (Phytotech) Thiamine HCL 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg0.5 mg 0.5 mg 0 0.5 mg (Sigma) 2,4-D (Phytotech) 0.5 mg 0.2 mg 0.2 mg0.5 mg 0.5 mg 0.2 mg 0 0 0.2 mg Sucrose (Phytotech) 30 g 30 g 30 g 30 g30 g 50 g 50 g 60 g 50 g Proline (Sigma) 1.38 g 1.38 g 1.38 g 1.38 g1.38 g 0 0 0 0 Casamino Acids 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg0.5 mg 0 0.5 mg (Difco) pH 5.8 5.8 5.8 5.8 5.8 5.8 5.8 5.8 5.8 Low EEOAgarose 5.5 g 5.5 g 5.5 g 5.5 g 0 0 0 0 0 (Sigma) Post autoclaveadditives Post filter sterilization additives Carbenicillin 50 mg 50 mg50 mg 50 mg 500 mg 500 mg 500 mg 500 mg 500 mg (Phytotech)Acetosyringone 200 μm 200 μm 200 μm 200 μm 0 0 0 0 0 (Aldrich) BAP(Sigma) 0 0.01 mg 0 0.01 mg 0.01 mg 0.01 mg 0.01 mg 0 0.01 mg Glyphosate0 0 0 0 0.2 mM 0.2 mM 0.1 mM 0.02 mM 0.2 mM (Gateway Chemical) SilverNitrate 3.4 mg 3.4 mg 3.4 mg 3.4 mg 3.4 mg 3.4 mg 0 0 0 (Sigma)

TABLE 3 Examples of other types of 2^(nd) medium used in the presentinvention. Media Components/L (Suppliers) 2347 2348 2414 2415 MS BasalSalts (Phytotech) 4.33 g 4.33 g 4.33 g 4.33 g MS Vitamins (100X)(Phytotech) 10 mL 10 mL 10 mL 10 mL Thiamine HCL (Sigma) 0 0.5 mg 0.5 mg0.5 mg Sucrose (Phytotech) 60 g 50 g 50 g 50 g Casamino Acids (Difco) 00.5 g 0.5 g 0.5 g pH 5.8 5.8 5.8 5.8 Post filter sterilization additivesCarbenicillin (Phytotech) 500 mg 500 mg 500 mg 500 mg BAP (Sigma) 0.01mg 0.01 mg 0.01 mg 0.01 mg Glyphosate (Gateway Chemical) 0.02 mM 0.2 mM0.05 mM 0.1 Silver Nitrate (Sigma) 3.4 mg 3.4 mg 3.4 mg 3.4 mg

To confirm the presence of the DNA construct in the regenerated plant, avariety of assays can be performed. Such assays include, for example,“molecular biological” assays, such as Southern and northern blottingand PCR™; “biochemical” assays, such as detecting the presence of aprotein product, e.g., by immunological means (ELISAs and western blots)or by enzymatic function; plant part assays, such as leaf or rootassays; and also, by analyzing the phenotype of the whole regeneratedplant.

Once a gene has been introduced into a plant using the present method,that gene can be introduced into any other plant sexually compatiblewith the first plant by crossing, without the need for directlytransforming the second plant. Therefore, as used herein the term“progeny” denotes the offspring of any generation of a parent plantprepared in accordance with the present invention. A “transgenic plant”may thus be of any generation.

The present invention also provides a plant and plant parts produced bythe method. Preferably, the plant is a monocot plant. More preferably,the monocot plant is a crop plant selected from the group consisting of:corn, rice, sorghum, wheat, rye, millet, sugarcane, oat, triticale,turfgrass, and switchgrass plants. In a particular embodiment themonocot plant is a corn plant. The plant parts include, withoutlimitation, seed, endosperm, ovule, pollen, leaf, stem, and root. In aparticular embodiment, the plant part is a seed. The invention alsoincludes and provides transformed plant cells and tissues produced bythe method.

The following examples illustrate the development of this method.

EXAMPLES

The following examples are included to illustrate embodiments of theinvention. It should be appreciated by those of skill in the art thatthe techniques disclosed in the examples that follow representtechniques discovered by the inventor to function well in the practiceof the invention. However, those of skill in the art should, in light ofthe present disclosure, appreciate that many changes can be made in thespecific embodiments which are disclosed and still obtain a like orsimilar result without departing from the concept, spirit and scope ofthe invention. More specifically, it will be apparent that certainagents which are both chemically and physiologically related may besubstituted for the agents described herein while the same or similarresults would be achieved. All such similar substitutes andmodifications apparent to those skilled in the art are deemed to bewithin the spirit, scope and concept of the invention as defined by theappended claims.

Example 1 Nucleic Acid Constructs and Transformation Agents

This example describes the making of the DNA constructs andtransformation of the DNA constructs into ABI Agrobacterium strain (adisarmed C58 strain) used for transformation of corn immature embryos.The plasmid pMON 97367 contains a cp4 gene as the selectable marker anda gus gene as the screenable marker driven by the chimeric rice actinand rice actin promoter, respectively. Strains of Agrobacterium wereprepared for transformation essentially according to proceduresdescribed elsewhere, such as Cai et al. (U.S. Patent Applic. Publn.2004/00244075).

Example 2 Improving Throughput of Transformation

This example describes the development of a revised method using liquidmedia during callus proliferation, selection, and during regenerationsteps in order to develop a simplified high throughput method needingless tissue handing and which is automatable. FIG. 1 shows anexperimental design for this 8 week liquid culture protocol (“LiquidPlug”-FIG. 1, middle diagram). Table 4 shows the results when comparedwith the method, essentially, of Cai et al (U.S. 2004/0244075, i.e. FIG.1, top diagram). The revised method is also modified from that found inExample 3, in that explants were transferred to a fourth medium (Lynx2063) after the first medium for one to two weeks at 30° C. in dark,transferred to a modified 2^(nd) medium (e.g. 2068; i.e. 2202 with addedAgNO₃), and then transferred to a fifth medium (e.g. Lynx 2066) afterthe second medium for one week at 27° C. in dark.

As noted above, certain corn transformation methods are described in theUS Patent Application Publication 2004/0244075 (Cai et al.), and variousmedia composition used are also described therein. Table 4 shows thattransgenic plants could be produced within 8 weeks by makingmodifications to the method of Cai et al., including culturing on the1^(st) culture medium for an extended period, reducing the culture timespent on the 4^(th) culture medium, reducing the culture time spent on5^(th) culture medium, and reducing the culture time spent on therooting medium used in the current method (Table 1). Additionally, the1^(st), 2^(rd), 3^(rd), 5^(th) media were modified (see Table 1 and 2)by adding cytokinin and reducing auxin, by substantially reducingcytokinin and adding a small amount of auxin and increasing sucroseamount, by removing all growth regulators and increasing sucrose, andadding a small amount of cytokinin and auxin and increasing sucrose,respectively. For example, Lynx 1233 used in a conventional methoddescribed in Cai et al. does not support prolonged growth anddevelopment of explant nor does it support shoot primordia formationlike the 1^(st) medium (Lynx 1947) of the current invention. Lynx 1278of Cai et al. have similar functions as Lynx 2063 of the currentinvention. The major difference between the two systems is in the areaof regeneration. Plant regeneration by the method of Cai et al. uses ahigh cytokinin pulse step (Lynx 1073), followed by shoot elongation(Lynx 1071) and finally rooting of plantlets accompanied by furthergrowth and development on Lynx 1084. In contrast, regeneration by thecurrent method is achieved by simultaneous development of shoot and rootby an auxin step-down approach (Lynx 2068 and Lynx 2066). Final growthand development of the plantlets are achieved on a growth regulator freemedium, Lynx 2067.

TABLE 4 Production of transgenic plants within 8 weeks using a liquidmedia culture method. % TF is the mean of at least 3 independentexperiments and is based on % of independent transgenic plant events. #of explants to selection # Events Treatment medium Produced TF (%)Control method 150 55 36.7 Liquid media method 210 125 59.5

Example 3 Transformation Method

This example describes a transformation method, including regenerationsteps (FIG. 1, “Rapid Transformation” scheme, bottom diagram), by whichis obtained, after about as little as 6 weeks of growth, a regeneratedplant in a solid growth medium (e.g. growth plug). In general, immatureembryos (IEs) were excised manually or via a fluid jet apparatus such asdisclosed in U.S. Pat. No. 7,150,993, or US Patent Application Publn.No. 2005/0246786, and inoculated with the Agrobacterium cells containingthe DNA construct of interest. The inoculated embryos were cultured onthe first medium (Lynx 1947) for about 7 (optionally to about 14) daysat 23° C. for 1 day and at 30° C. for the rest of the time in dark,after which explants were transferred to a Petri plate containing asupport such as felt and/or filter paper (e.g. Ahlstrom grade 610, 8.22cm; Ahlstrom Corp., Helsinki, Finland) and 10 ml of a second medium(Lynx 2202), and the plates were incubated at 30° C. under darkconditions for about 1 week. After one week in the presence of thesecond medium, the old medium was aspirated off and 10 ml of the thirdmedium (Lynx 2067) was added and the plates were incubated at 30° C. indark for one more week. At approximate one week intervals after theinitial transfer to the third medium, old medium was aspirated off andabout 15-30 ml of the third medium was added again and plates wereincubated at 27-30° C. in 16/8 light-dark. After the 6^(th) weekpost-transformation, plants were transferred to plugs containing a solidgrowth medium, under non-sterile conditions for hardening and then topots for further growth and development within the next 2 weeks. Themedia compositions used are shown in Table 2.

Example 4 Use of Cytokinin Facilitates Rapid Production of Shoots andPlants

This example illustrates the use of cytokinin for initiating early shootprimordia formation for faster production of transgenic plants.Experiments were performed with or without BAP in the first medium (seeTable 2 for components) and the results are shown in Table 5. FIG. 2shows the production of shoot primordia on the first medium. The resultsalso show significant improvement in transformation frequency when thecytokinin was used during this step of the transformation process.

TABLE 5 Use of a cytokinin during the first step of transformationprocess enhances transformation frequency due to early shoot primordiaformation. % TF is average of 4 experiments and is based on % ofindependent transgenic plant events. Treatment # of embryos Total #Events % TF (1 week) to selection Produced Mean ± SD Lynx 1898; No BAP315 41 13.0 ± 7.4 Lynx 1947; BAP 365 179 49.0 ± 2.3

Example 5 Simplification of Methods by Decreasing Callus Proliferationand Selection Period

This example demonstrates production of transgenic plants within 7 and 6weeks by decreasing the time spent on Lynx 2063 by 1 week and thuslimiting callus proliferation. The outline of the experiment and resultsare shown in Table 6. The results suggest that a reduced callusing phasecan be used without affecting TF. The results also suggested that afurther reduction or elimination in callusing phase may be possiblewhich may speed-up the process of transgenic plant production.

TABLE 6 Production of transgenic plants within 7 or 6 weeks by reducingthe callusing phase. % TF is the mean of at least 3 independentexperiments and is based on % independent transgenic plant events. STEPSTreatment 1 Treatment 2 Treatment 3 Co culture and Lynx 1947 Lynx 1947Lynx 1947 Delay; 8-10 days 1st transfer; 1 wk Lynx 2063 Lynx 2063 Lynx2063 2nd transfer, 1 wk Lynx 2063 Lynx 2068 Lynx 2068 3rd transfer, 1 wkLynx 2068 Lynx 2066 Lynx 2067 4th transfer, 1 wk Lynx 2066 Lynx 2067Lynx 2067 5th transfer, 2 wks Lynx 2067 Lynx 2067 plug (6 wks) 6thtransfer, 1 wk Lynx 2067 plug (7 wks) N/A 7th transfer plug (8 wks) N/AN/A TF (Mean ± SD) 16.9 ± 1.0 26.0 ± 10.9 22.0 ± 5.9

Example 6 Development of Six Week Transformation Protocol by EliminatingCallus Proliferation During Selection

This example demonstrates the production of transgenic plants within 6weeks by eliminating the callus proliferation and selection step (Lynx2063, 4^(th) medium) and one of the regeneration steps, on the fifthmedium, completely. The experimental design and the results are shown inTable 7. This experiment included an already shortened method(treatment 1) with one week callus proliferation/selection step on thefourth medium and compared it with a method including directregeneration on the second medium that contained a lower 2, 4-D levelthan the first medium. Thus in addition to reducing auxin level, anincreased ratio of shoot forming growth regulator to auxin is alsocontemplated. This example demonstrates that the need for callus growthand proliferation step during selection (the fourth and the fifth mediae.g. 2063 and 2066 media) can be eliminated and is crucial to obtaintransgenic events in a reduced amount of time.

TABLE 7 Production of Transgenic Plants by Eliminating the CallusProliferation Step. % TF is the mean of at least 3 independentexperiments and is based on % independent transgenic plant events. STEPSTreatment 1 Treatment 2 Co-culture and Delay; 8-10 Lynx 1947 Lynx 1947days 1st transfer, 1 wk Lynx 2063 Lynx 2202 2nd transfer, 1 wk Lynx 2068Lynx 2068 3rd transfer, 1 wk Lynx 2066 Lynx 2067 4th transfer, 1 wk Lynx2067 Lynx 2067 5th transfer, 2 wks Lynx 2067 Lynx 2067 6th transfer, 1wk Lynx 2067 Plug 7th transfer Plug TF (Mean ± SD) 18.8 ± 9.4 40.9 ±18.7

Example 7 Some Callus Proliferation During Co-Culture and Delay isRequired for Enhanced TF

This example illustrates the role of appropriate cell proliferation ofexplants during co-culture and delay medium (the first medium) on TF.The callus growth of the explants was controlled by the level of 2,4-Din the co-culture/delay medium. As shown in Table 8 the effect of oneweek culture on the 1st medium (e.g., 2232, 1947, 2233 or 1898; Table 2)was tested, followed by a six week transformation protocol. It isevident from the results that amount of callusing duringco-culture/delay before regeneration determines TF. An auxin level at alower concentration i.e. 0.2 mg/L in Lynx 2232 had zero TF whileexplants cultured on 1947 having 0.5 mg/L gave a TF of about 35%. Theresults suggest that some callus proliferation before growth on 2^(nd)medium (including regeneration) is necessary to allow for later shootbud formation. The amount of callus formation may be optimized byvarying the tissue culture parameters including, among others, mediacomponents and duration of growth.

TABLE 8 Optimum callus phase during co-culture and delay impacts TF. %TF is the mean of at least 3 independent experiments and is based on %of independent transgenic plant events. Treatment STEPS Treatment 1Treatment 2 Treatment 3 4 Co-culture and Lynx 2232 Lynx 1947 Lynx 2233Lynx 1898 Delay; 1 wk (7-10 days) 1st transfer; 1 wk Lynx 2202 Lynx 2202Lynx 2202 Lynx 2202 2nd transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067Lynx 2067 3rd transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 Lynx 2067 4thtransfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 Lynx 2067 5th transfer, 1wk Plug Plug Plug Plug TF 0 35.4 0.7 6.1

Example 8 Further Simplifications to Protocol

This example illustrates reducing the duration of growth of explants onregeneration medium (2202) for further simplifying the methods whilestill allowing obtention of plants within 6 weeks while having noadverse effect on TF. In this study shown in Table 9, the effect of oneweek each on the second medium (2202; 2068) (treatment 1) was comparedwith only one week on the second medium 2202 (treatment 2 and 3)followed by elongation on the third medium (2067). The second medium2202 is identical to 2068 except that 2068 does not have 3.4 mg/L silvernitrate. The third medium (2067) was added at regular intervals(treatment 2) or the spent medium was removed and fresh medium was added(treatment 3). The replacement or dilution of 2202 with 2067 is likelyto enhance regeneration. The size range of the plants produced by thismethod was adequate for transplanting to a plug and had a survival rateof almost 100%. Copy number analysis of nearly 170 events using Taqman®assay on the 3′ region of the pin II transcription termination sequencegene present in the expression unit of the DNA construct used fortransformation revealed that about 78% of the plants contained 1-2 copy,indicating production of higher percentage of usable plants as comparedto only about 60% of plants with 1-2 copies as typically obtained withthe current method. Only three plants from the experiment had zero copyindicating very few escapes. Transgenic plants could also be producedfor transplanting within as little as 4 weeks as shown in FIG. 3A.

TABLE 9 Production of transgenic plants using a new regeneration andelongation medium. % TF is the mean of at least 2 independentexperiments and is based on % of independent transgenic plant events.STEPS Treatment 1 Treatment 2 Treatment 3 Co-culture and Delay; Lynx1947 Lynx 1947 Lynx 1947 1 wk (7-10 days) 1st transfer; 1 wk Lynx 2202Lynx 2202 Lynx 2202 2nd transfer, 1 wk Lynx 2068 Lynx 2067 Lynx 2067 3rdtransfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 4th transfer, 1 wk Lynx2067 Lynx 2067 Lynx 2067 5th transfer, 1 wk Lynx 2067 Lynx 2067 Lynx2067 6th transfer Plug Plug Plug TF 27.1 33.8 40.6

Example 9 Alternative Two and Three Step Protocols

This example illustrates production of transgenic plants by furtherreducing the number of transfer steps and/or aspiration/addition ofmedia steps and/or media as shown in FIG. 4 and in Tables 10 and 11. Oneimportant component of the present method is a short callus phase whilespeeding-up the regeneration at the same time. In this approach,following co-culture/delay (1^(st) medium), tissues were transferred toa regeneration medium (2^(nd) medium; e.g. 2202) for a week to speed-upthe regeneration process (Table 10). However, such a step couldinterfere with easy automation of this method as this 2^(nd) medium,comprising auxin which delays elongation, would need to be removed priorto adding the 3^(rd) medium (e.g. growth and elongation medium 2067).This issue was overcome by identifying a different second medium withoutany auxin but some cytokinin (e.g. 2347, 2348, 2415, 2414) as theregeneration medium which can support regeneration, elongation andgrowth in place of the 2nd medium (i.e. 2202), thereby removing the needto aspirate off the medium. In treatments 2, 3, 4, and 5 after the firsttransfer, growth regulator free 2067 was added to the containers. The2^(nd) medium used in treatment 5 is a modified version of Lynx 2067 asit contains small amount of BAP and may be used for regeneration andelongation as it does not contain any auxin (e.g. 2347) as shown withthe success of treatment 5. Thus, as shown in FIG. 4, bottom, a rapidand simple plant transformation protocol displaying excellent TF, andconsisting of only two media steps, is achieved. Furthermore, theability to simply add medium without aspirating off the old medium makesthe system amenable for automation.

TABLE 10 Production of transgenic plants in three culture steps. #plants to Total # Events Expt # Treatment selection Produced % TF 8205-18 wks - Liquid 110 46 41.8 8205-2 6 wks - Liquid 100 38 38.0 8205-3 6weeks-liquid with 48 20 41.7 transformation in three steps

As shown in Table 11, transformation was achieved across all thetreatments, indicating that elimination of auxin containing medium(2202) is possible without affecting TF. Additionally, transformationusing regeneration and elongation medium comprising no auxin and somecytokinin following the co-culture/delay was possible as shown with2347, 2348, 2414, and 2415 contain glyphosate at the concentration shownin parentheses.

TABLE 11 Experimental design for Testing Production of Transgenic Plantsin Two Steps. For media compositions see Tables 2 and 3. STEPS Treatment1 Treatment 2 Treatment 3 Treatment 4 Treatment 5 Co-culture and Lynx1947 Delay; 10 days 1st transfer; 1 wk, 2202 2348 2415 2414 2347 dark 30C. (0.2 mM) (0.1 mM) (0.02 mM) (0.1 mM) 2nd transfer; 1 wk, Lynx 2067dark 30 C. 4th transfer; 3 wks, Lynx 2067 light 27 C. 5th transfer PlugTF ± SD 48.9 ± 9.5 46.5 ± 9.7 39.5 ± 12.5 40.5 ± 7.5 42.5 ± 9.7

Example 10 Transformation of Recalcitrant Corn Genotypes

This example illustrates production of transgenic plants using arecipient elite corn variety which was found to possess a poorembryogenic culture response (i.e. is considered “recalcitrant”)relative to a control elite genotype commonly used for transformationvia method comprising a separate step of callus formation duringselection as described by Cai et al. Only one transgenic event wasobtained from 6 experiments utilizing about 1172 explants with thecontrol line, whereas two studies utilizing the rapid transformationmethods of the present invention resulted in TF's of about 16.9% and19.5%, indicating that these methods can be successfully applied torecalcitrant lines. In Table 12, % TF is the mean of 4 independentexperiments and is based on % of independent transgenic plant events. Insome experiments a TF of about 30-40% could be obtained.

TABLE 12 Modified RLC to facilitate production of plants of an eliteline in about 6 weeks. STEPS Treatment 3 Treatment 4 Co-culture and Lynx1947 Lynx 1947 delay 2nd Transfer (dark Lynx 2063 (callus proliferationand Lynx 2202 30° C.) selection) (regeneration) 3rd Transfer (dark Lynx2063 (callus proliferation and Lynx 2202 30° C.) selection)(regeneration) 4th Transfer (dark Lynx 2068 (regeneration) Lynx 2068 30°C.) (regeneration) 5th Transfer (light Lynx 2067 (elongation and growth)Lynx 2067 27° C.) (elongation and growth) 6th Transfer (light Lynx 2067(elongation and growth) Lynx 2067 27° C.) (elongation and growth) ToPlug To Plug To Plug TF % 16.9 19.5

Example 11 Methods for Evaluating Transformability of Corn Lines

This example illustrates rapid identification of genotypes fortransformation competence in a few simple steps. In this method,explants are cultured on a medium capable of producing shoot primordiain a short time (medium such as 1947; Table 2). One week post culture,the explants are transferred to a regeneration/elongation medium (e.g.Lynx 2424; Table 13) for 2-3 weeks at 30° C. in dark conditions. Linesproducing plantlets can be transferred to a growth medium (e.g. Lynx2427; Table 13) for a period of 2-3 wks. Lines capable of producingand/or regenerating shoot buds through this screening approach will beamenable to a rapid transformation procedure such as outlined above,without the need for a separate callus formation step during theirculture.

TABLE 13 Media Used for Evaluating Transformability of Corn Lines MediaComponents/L (Suppliers) 2424 2427 MS Basal Salts (Phytotech) 4.33 g4.33 g MS Vitamins (100X) (Phytotech) 10 mL 10 mL Thiamine HCL (Sigma)0.5 mg 0 Sucrose (Phytotech) 50 g 60 g Proline (Sigma) 1.38 0 CasaminoAcids (Difco) 0.5 g 0 Adjust pH to 5.8 5.8 Phytagar (Gibco) 6 5.5 g Postautoclave additives BAP (Sigma) 0.01 mg/l 0

Example 12 Reduced Product Development Cycle Time Via RapidTransformation

The invention also provides an expanded priority development window fortransgenic plant product development. Such product development is alengthy process—it can take a minimum of 7-8 years to proceed from anidea and a gene to a commercial product in the form of hybrid corn seedsold to growers. The field of plant biotechnology, and specificallytransgenic corn product development, is highly competitive and removingone or more years from a product development cycle can give a companyhuge returns in market share and revenue.

Using a plant (e.g. corn) transformation protocol that takes about 11-12weeks to produce transformed plants, the development window typicallyextends from late November to early January. Subsequent to collectionand analysis of Midwest U.S. yield data in any given year, the window oftime remaining after data collection to initiate new transformationsbased on that data, while being able to yield test resultingtransformants as hybrids in the second subsequent Midwest growing seasonis limited to no later than early January, due to the subsequentactivities outlined in FIG. 5. These activities include cultivating R0generation plant and performing event characterization, completion of R0plant development including pollination and seed preparation, R1 plantdevelopment including identification of homozygotes and collection ofseed, and finally cultivation of another generation to create hybridsand to distribute seed to field testing locations.

An acceleration of transgenic corn product development is achieved byshortening the time required for corn transformation (time from DNAintroduction into cells until plants to soil) such that one fullcalendar year is removed from the product development cycle of the cornproduct development pipeline. This is accomplished by shortening thecorn transformation protocol from 11-12 weeks or more, to 6-7 weeks orless as shown in blue in FIG. 5. This expands the “priority developmentwindow”, which is defined as the time from when Midwest U.S. yield datais available in any given growing season until the last possible date atwhich a transformation can be initiated and transformed lines resultingfrom these transformations can be yield tested in the U.S. as hybrids,in the second sequential U.S. growing season subsequent to the time oftransformation. Yield data generated in the Midwest is critical to U.S.product development regardless of the product. Using a 6-7 weektransformation protocol expands the priority development window by 5-6weeks (FIG. 5), allowing for more time to make business criticaldecisions or up to twice the transformation capacity with no increase intransformation resources in a timeframe such that yield testing oftransformants initiated in the priority development window is possiblein the second subsequent growing season (FIG. 5) instead of waiting fora full calendar year before yield testing these transformants.

All of the compositions and methods disclosed and claimed herein can bemade and executed without undue experimentation in light of the presentdisclosure. While the compositions and methods of this invention havebeen described in terms of the foregoing illustrative embodiments, itwill be apparent to those of skill in the art that variations, changes,modifications, and alterations may be applied to the composition,methods, and in the steps or in the sequence of steps of the methodsdescribed herein, without departing from the true concept, spirit, andscope of the invention. More specifically, it will be apparent thatcertain agents that are both chemically and physiologically related maybe substituted for the agents described herein while the same or similarresults would be achieved. All such similar substitutes andmodifications apparent to those skilled in the art are deemed to bewithin the spirit, scope, and concept of the invention as defined by theappended claims.

REFERENCES

The following references, to the extent they provide exemplaryprocedural or other details supplementary to those set forth herein, arespecifically incorporated herein by reference:

-   U.S. Pat. Nos. 4,769,061, 4,757,011, 4,971,908, 4,940,835,    4,971,908, 5,352,605, 5,641,876, 6,294,714, and 7,150,993-   U.S. Patent Application Publn. 2004/0244075; US Patent Application    Publn. 2005/0246786-   U.S. patent application Ser. No. 11/749,583-   Broothaerts et al., Nature, 433:629-633, 2005.-   Chu et al., Scientia Sinica, 18:659-668, 1975.-   Duncan et al., Planta, 165:322-332, 1985.-   Frame et al., Plant Physiol., 129:13-22, 2002.-   Frame et al., Plant Cell Rep., 25:1024-1034, 2006.-   Gamborg et al., Exp. Cell Res., 50:151-158; 1968.-   Ishida et al., Nature Biotech., 14:745-750, 1996.-   Linsmaier and Skoog, Physiol. Plant., 18 100, 1965.-   Matthys-Rochon et al., J. Exp. Bot., 49:839-845, 1998.-   McCown and Lloyd, HortScience, 16:453, 1981.-   Mild and McHugh, J. Biotechnol., 107:193-232, 2004.-   Murashige and Skoog, Physiol. Plant, 15:473-497, 1962.-   Nitsch and Nitsch, Science, 163:85-87, 1969.-   Sambrook et al., In: Molecular cloning, Cold Spring Harbor    Laboratory Press, Cold Spring Harbor, N.Y., 2000.-   Schenk and Hildebrandt, Can. J. Bot., 50: 199-204, 1972.-   Toki et al. Plant J. 47:969-978, 2006.-   Uchimiya and Murashige, Plant Physiol. 15:73, 1962.-   Zhao et al., Molec. Breeding, 8:323-333, 2001.

What is claimed is:
 1. A method for producing a transgenic corn plantcomprising: a) transforming an explant with at least a first selectedDNA via bacterially mediated transformation of the explant; b) culturingthe explant in a first culture medium comprising an effective ratio ofcytokinin and auxin to promote development of regenerable structurescapable of root and/or shoot formation; and c) culturing the explant inat least a second culture medium comprising a reduced amount of auxinrelative to the first culture medium, and/or a third culture medium thatlacks auxin and cytokinin, wherein the second culture medium and/orthird culture medium supports the simultaneous growth of root and shoottissues, to produce a regenerated transgenic corn plant; wherein theratio of cytokinin to auxin in the first culture medium is from about0.005 to about 0.03 (w/w), wherein the first culture medium comprisesfrom about 0.001 mg/L to about 10 mg/L of cytokinin and from about 0.1mg/L to about 15 mg/L auxin, and wherein the regenerated transgenic cornplant is produced within about 4-8 weeks of transforming the explant. 2.The method of claim 1, further comprising: d) transferring theregenerated transgenic corn plant to a plant growth medium.
 3. Themethod of claim 2, wherein the plant growth medium is a non-sterilematrix.
 4. The method of claim 3, wherein the non-sterile matrix iscomprised in a plug.
 5. The method of claim 1, wherein the regenerablestructures are formed within about 6-14 days of transforming theexplant.
 6. The method of claim 1, wherein step b) is completed withinabout 6-14 days of transforming the explant.
 7. The method of claim 1,wherein steps a) and b) are carried out without proliferating a callusfor more than about 10 days to two weeks.
 8. The method of claim 1,wherein the first culture medium comprises a bactericidal compound. 9.The method of claim 1, wherein the second and/or third culture mediumcomprises sucrose at a concentration higher than in the first culturemedium.
 10. The method of claim 1, wherein the first culture mediumcomprises Lynx 1947 medium of Table
 2. 11. The method of claim 1,wherein step (c) comprises culturing the explant in an added plantgrowth regulator-free liquid culture medium that supports thesimultaneous growth of root and shoot tissues, to produce theregenerated transgenic corn plant.
 12. The method of claim 11, whereinthe third culture medium comprises Lynx 2067 medium of Table
 2. 13. Themethod of claim 1, wherein step (b) is carried out for a length of fromabout 6 days to about 12 days.
 14. The method of claim 1, wherein thecytokinin is selected from the group consisting of BAP, zeatin, kinetin,and TDZ; and the auxin is selected from the group consisting of IAA,2,4-D, NAA, IBA, and dicamba.
 15. The method of claim 1, and whereinstep (c) comprises culturing the explant in the second culture medium,wherein the second culture medium comprises an increased ratio ofcytokinin to auxin relative to the first medium to promote developmentof root(s) and shoot(s) simultaneously.
 16. The method of claim 15,wherein the second culture medium of step (c) is Lynx 2202 medium ofTable 2 and/or Lynx 2068 medium of Table
 2. 17. The method of claim 1,wherein step (c) comprises culturing the explant in a third culturemedium lacking plant growth regulators.
 18. The method of claim 15,wherein the ratio of shoot forming growth regulator to auxin in thesecond medium is from about 0.02 to about 0.06 (w/w).
 19. The method ofclaim 15, wherein the second medium is Lynx 2202 medium of Table 2 orLynx 2068 medium of Table
 2. 20. The method of claim 1, wherein freshgrowth medium is not added subsequent to the start of step (c).
 21. Themethod of claim 15, wherein the explant is further cultured on a fourthmedium between culturing on the first culture medium and the secondculture medium, wherein the fourth medium comprises an effective amountof auxin and cytokinin to promote callus proliferation.
 22. The methodof claim 21, wherein the fourth medium is Lynx 2063 medium of Table 2.23. The method of claim 21, wherein the explant is further cultured on afifth medium between culturing on the second culture medium and thethird culture medium, wherein the fifth medium comprises an amount ofcytokinin effective to promote shoot growth.
 24. The method of claim 23,wherein the fifth medium is Lynx 2066 medium of Table
 2. 25. The methodof claim 1, wherein the bacterially mediated transformation is carriedout using a bacterium selected from the group consisting ofAgrobacterium sp., Rhizobium sp., Sinorhizobium sp., Mesorhizobium sp.,and Bradyrhizobium sp.
 26. The method of claim 18, wherein the shootforming growth regulator comprises cytokinin, abscisic acid, or acombination of cytokinin and abscisic acid.
 27. The method of claim 26,wherein the second culture medium comprises less than half as much auxinas the first culture medium.
 28. The method of claim 1, wherein thefirst culture medium and the at least second and/or third culture mediumthat supports the simultaneous growth of root and shoot tissues areliquid media.
 29. The method of claim 1, wherein the first culturemedium is a semi-solid medium.
 30. The method of claim 1, wherein eachmedium used subsequent to the first culture medium is a liquid medium.31. The method of claim 1, wherein steps b) and c) are carried out in asingle container.
 32. The method of claim 1, wherein the explant is animmature embryo.
 33. The method of claim 1, wherein the first culturemedium comprises from about 0.1 mg/L to about 10 mg/L auxin, and fromabout 0.005 mg/L to about 0.05 mg/L cytokinin.
 34. The method of claim17, wherein the third culture medium lacks silver nitrate.